• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于单载物抗体药物偶联物的二硫键重桥连试剂。

Disulfide re-bridging reagents for single-payload antibody-drug conjugates.

机构信息

Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.

Department of Organic Chemistry, Faculty of Science, Palacky University, Tr. 17. Listopadu 12, Olomouc, 77900, Czech Republic.

出版信息

Chem Commun (Camb). 2023 Aug 10;59(65):9868-9871. doi: 10.1039/d3cc02980h.

DOI:10.1039/d3cc02980h
PMID:37492000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10414422/
Abstract

Numerous antibody-drug conjugate (ADC) linker technologies exist for the synthesis of ADCs with drug-to-antibody ratios (DARs) being an even integer (typically 2, 4 or 8). However, ADCs with odd-integer DARs are significantly harder to synthesise. Here, we report the synthesis of ADCs loaded with a single warhead, using TetraDVP linkers which simultaneously re-bridge all four interchain disulfides of an IgG1 antibody.

摘要

存在许多抗体药物偶联物 (ADC) 连接子技术,可用于合成药物抗体比 (DAR) 为偶数整数(通常为 2、4 或 8)的 ADC。然而,奇数整数 DAR 的 ADC 更难合成。在这里,我们报告了使用 TetraDVP 接头合成负载单个弹头的 ADC 的方法,该接头可同时重新桥接 IgG1 抗体的所有四个链间二硫键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/8539045f739e/d3cc02980h-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/d296d6043cd3/d3cc02980h-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/c602e3ca44ee/d3cc02980h-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/2f70d96816fd/d3cc02980h-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/8539045f739e/d3cc02980h-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/d296d6043cd3/d3cc02980h-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/c602e3ca44ee/d3cc02980h-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/2f70d96816fd/d3cc02980h-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eb9/10414422/8539045f739e/d3cc02980h-f3.jpg

相似文献

1
Disulfide re-bridging reagents for single-payload antibody-drug conjugates.用于单载物抗体药物偶联物的二硫键重桥连试剂。
Chem Commun (Camb). 2023 Aug 10;59(65):9868-9871. doi: 10.1039/d3cc02980h.
2
Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.二硫键异构体对半胱氨酸连接的 IgG2 抗体药物偶联物中药物结合点的影响。
MAbs. 2018 May/Jun;10(4):583-595. doi: 10.1080/19420862.2018.1440165. Epub 2018 Mar 6.
3
Antibody-Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs.源于链间半胱氨酸交联的抗体-药物偶联物(ADC)相较于传统的异质性ADC,展现出更高的均一性和其他药理特性。
Mol Pharm. 2015 Nov 2;12(11):3986-98. doi: 10.1021/acs.molpharmaceut.5b00432. Epub 2015 Oct 2.
4
The Chemical Design and Synthesis of Linkers Used in Antibody Drug Conjugates.抗体药物偶联物中连接子的化学设计与合成
Curr Top Med Chem. 2017;17(32):3393-3424. doi: 10.2174/1568026618666180118155847.
5
Cleavable linkers in antibody-drug conjugates.抗体药物偶联物中的可裂解连接子。
Chem Soc Rev. 2019 Aug 12;48(16):4361-4374. doi: 10.1039/c8cs00676h.
6
Bis(vinylsulfonyl)piperazines as efficient linkers for highly homogeneous antibody-drug conjugates.双(乙烯砜基)哌嗪作为高效连接子用于高度均一的抗体药物偶联物。
Eur J Med Chem. 2020 Mar 15;190:112080. doi: 10.1016/j.ejmech.2020.112080. Epub 2020 Jan 22.
7
Homogeneous antibody-drug conjugates via site-selective disulfide bridging.通过位点选择性二硫键桥连的均相抗体-药物偶联物
Drug Discov Today Technol. 2018 Dec;30:11-20. doi: 10.1016/j.ddtec.2018.09.004. Epub 2018 Oct 12.
8
The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.半胱氨酸结合型抗体药物偶联物的性质受 IgG 亚型影响。
AAPS J. 2018 Sep 25;20(6):103. doi: 10.1208/s12248-018-0263-0.
9
Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers.利用自裂解二硫键连接子调节吡咯并苯二氮䓬抗体药物偶联物的治疗活性和毒性
Mol Cancer Ther. 2017 May;16(5):871-878. doi: 10.1158/1535-7163.MCT-16-0641. Epub 2017 Feb 21.
10
All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading.一体化二硫键桥接能够生成具有模块化载药功能的抗体偶联物。
Chem Sci. 2022 Jul 20;13(30):8781-8790. doi: 10.1039/d2sc02198f. eCollection 2022 Aug 4.

引用本文的文献

1
Unsaturated Phosphine Oxides for Modular Antibody Rebridging and Single Reagent Peptide-Cyclization-Bioconjugation.用于模块化抗体再桥连和单试剂肽环化-生物共轭的不饱和氧化膦
Angew Chem Int Ed Engl. 2025 Sep 15;64(38):e202508656. doi: 10.1002/anie.202508656. Epub 2025 Aug 8.
2
A platform for SpyCatcher conjugation to native antibodies.一个用于将SpyCatcher与天然抗体偶联的平台。
Chem Sci. 2025 May 6. doi: 10.1039/d5sc02286j.
3
Methods for the Generation of Single-Payload Antibody-Drug Conjugates.单有效载荷抗体-药物偶联物的生成方法。

本文引用的文献

1
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology.利用定制的 GlycoConnect 技术生成用于超效荷载的 DAR1 抗体药物偶联物。
Bioconjug Chem. 2023 Mar 15;34(3):538-548. doi: 10.1021/acs.bioconjchem.2c00611. Epub 2023 Mar 1.
2
All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading.一体化二硫键桥接能够生成具有模块化载药功能的抗体偶联物。
Chem Sci. 2022 Jul 20;13(30):8781-8790. doi: 10.1039/d2sc02198f. eCollection 2022 Aug 4.
3
An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy.
ChemMedChem. 2025 May 19;20(10):e202500132. doi: 10.1002/cmdc.202500132. Epub 2025 Mar 19.
4
Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenies of rheumatoid arthritis.具有双功能抗炎作用的抗体-药物偶联物在类风湿关节炎发病机制中的治疗潜力
Arthritis Res Ther. 2024 Dec 19;26(1):216. doi: 10.1186/s13075-024-03452-0.
5
Peptide and Protein Cysteine Modification Enabled by Hydrosulfuration of Ynamide.通过烯炔酰胺的氢硫化实现的肽和蛋白质半胱氨酸修饰
ACS Cent Sci. 2024 Aug 21;10(9):1742-1754. doi: 10.1021/acscentsci.4c01148. eCollection 2024 Sep 25.
6
Facile Rebridging Conjugation Approach to Attain Monoclonal Antibody-Targeted Nanoparticles with Enhanced Antigen Binding and Payload Delivery.一种简便的重新桥连共轭方法,用于获得具有增强抗原结合和载荷递送能力的单克隆抗体靶向纳米颗粒。
Bioconjug Chem. 2024 Sep 10;35(10):1491-502. doi: 10.1021/acs.bioconjchem.4c00275.
深入了解 FDA 批准用于癌症治疗的抗体药物偶联物。
Molecules. 2021 Sep 27;26(19):5847. doi: 10.3390/molecules26195847.
4
Automated linkage of proteins and payloads producing monodisperse conjugates.蛋白质与有效载荷的自动连接产生单分散缀合物。
Chem Sci. 2020 Jan 2;11(5):1210-1215. doi: 10.1039/c9sc05468e.
5
Site-selective modification strategies in antibody-drug conjugates.抗体药物偶联物中的位点选择性修饰策略。
Chem Soc Rev. 2021 Jan 21;50(2):1305-1353. doi: 10.1039/d0cs00310g. Epub 2020 Dec 8.
6
A Purification Strategy Utilizing Hydrophobic Interaction Chromatography to Obtain Homogeneous Species from a Site-Specific Antibody Drug Conjugate Produced by AJICAP™ First Generation.一种利用疏水相互作用色谱法从AJICAP™第一代生产的位点特异性抗体药物偶联物中获得均一产物的纯化策略。
Antibodies (Basel). 2020 May 18;9(2):16. doi: 10.3390/antib9020016.
7
Highly Efficient Mono-Functionalization of Knob-in-Hole Antibodies with Strain-Promoted Click Chemistry.通过应变促进的点击化学实现孔中旋钮抗体的高效单功能化。
ACS Omega. 2019 Jul 8;4(7):11801-11807. doi: 10.1021/acsomega.9b01727. eCollection 2019 Jul 31.
8
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.采用工程化抗体和双马来酰亚胺吡咯苯并二氮杂卓二聚体制备药物抗体比为 1 的均一抗体药物偶联物的设计与表征。
MAbs. 2019 Apr;11(3):500-515. doi: 10.1080/19420862.2019.1578611. Epub 2019 Mar 5.
9
Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering.无需抗体工程即可实现两个模块负载的抗体缀合物的可控组装。
Chem Sci. 2017 Mar 1;8(3):2056-2060. doi: 10.1039/c6sc03655d. Epub 2016 Nov 28.
10
Antibody conjugation via one and two C-terminal selenocysteines.通过一个和两个 C 末端硒代半胱氨酸进行抗体偶联。
Methods. 2014 Jan 1;65(1):133-8. doi: 10.1016/j.ymeth.2013.05.023. Epub 2013 Jun 10.